These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 8048164)

  • 21. The CIS family: negative regulators of JAK-STAT signaling.
    Yoshimura A
    Cytokine Growth Factor Rev; 1998; 9(3-4):197-204. PubMed ID: 9918119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Jaks and Stats in cytokine signaling.
    Ihle JN; Nosaka T; Thierfelder W; Quelle FW; Shimoda K
    Stem Cells; 1997; 15 Suppl 1():105-11; discussion 112. PubMed ID: 9368330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of the Jak-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cells.
    Witthuhn BA; Silvennoinen O; Miura O; Lai KS; Cwik C; Liu ET; Ihle JN
    Nature; 1994 Jul; 370(6485):153-7. PubMed ID: 8022486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The thrombopoietin receptor can mediate proliferation without activation of the Jak-STAT pathway.
    Dorsch M; Fan PD; Danial NN; Rothman PB; Goff SP
    J Exp Med; 1997 Dec; 186(12):1947-55. PubMed ID: 9396763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The structure, regulation and function of the Janus kinases (JAKs) and the signal transducers and activators of transcription (STATs).
    Pellegrini S; Dusanter-Fourt I
    Eur J Biochem; 1997 Sep; 248(3):615-33. PubMed ID: 9342212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Signal transduction through cytokine receptors.
    Hibi M; Hirano T
    Int Rev Immunol; 1998; 17(1-4):75-102. PubMed ID: 9914944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-3 signaling and the role of Src kinases, JAKs and STATs: a covert liaison unveiled.
    Reddy EP; Korapati A; Chaturvedi P; Rane S
    Oncogene; 2000 May; 19(21):2532-47. PubMed ID: 10851052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of the JAK-STAT signal transduction pathway by oncostatin-M cultured human and mouse osteoblastic cells.
    Levy JB; Schindler C; Raz R; Levy DE; Baron R; Horowitz MC
    Endocrinology; 1996 Apr; 137(4):1159-65. PubMed ID: 8625884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new protein containing an SH2 domain that inhibits JAK kinases.
    Endo TA; Masuhara M; Yokouchi M; Suzuki R; Sakamoto H; Mitsui K; Matsumoto A; Tanimura S; Ohtsubo M; Misawa H; Miyazaki T; Leonor N; Taniguchi T; Fujita T; Kanakura Y; Komiya S; Yoshimura A
    Nature; 1997 Jun; 387(6636):921-4. PubMed ID: 9202126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors.
    Stahl N; Farruggella TJ; Boulton TG; Zhong Z; Darnell JE; Yancopoulos GD
    Science; 1995 Mar; 267(5202):1349-53. PubMed ID: 7871433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cytokine signaling].
    Chida D; Miyajima A
    Tanpakushitsu Kakusan Koso; 1997 Jul; 42(10 Suppl):1525-31. PubMed ID: 9279077
    [No Abstract]   [Full Text] [Related]  

  • 32. Stem cell factor, the JAK-STAT pathway and signal transduction.
    Linnekin D; Mou S; Deberry CS; Weiler SR; Keller JR; Ruscetti FW; Longo DL
    Leuk Lymphoma; 1997 Nov; 27(5-6):439-44. PubMed ID: 9477125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advances in the understanding of cytokine signal transduction: the role of Jaks and STATs in immunoregulation and the pathogenesis of immunodeficiency.
    O'Shea JJ; Notarangelo LD; Johnston JA; Candotti F
    J Clin Immunol; 1997 Nov; 17(6):431-47. PubMed ID: 9418183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unexpected transcriptional signals in normal and mitotically defective cells mediated through cytokine and growth factor receptors.
    Samanta A; Qian X; Greene MI
    DNA Cell Biol; 1995 Nov; 14(11):921-30. PubMed ID: 7576178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contributions of leukemia inhibitory factor receptor and oncostatin M receptor to signal transduction in heterodimeric complexes with glycoprotein 130.
    Hermanns HM; Radtke S; Haan C; Schmitz-Van de Leur H; Tavernier J; Heinrich PC; Behrmann I
    J Immunol; 1999 Dec; 163(12):6651-8. PubMed ID: 10586060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Jak-STAT pathway stimulated by interferon gamma.
    Horvath CM
    Sci STKE; 2004 Nov; 2004(260):tr8. PubMed ID: 15561980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An alternative pathway for STAT activation that is mediated by the direct interaction between JAK and STAT.
    Fujitani Y; Hibi M; Fukada T; Takahashi-Tezuka M; Yoshida H; Yamaguchi T; Sugiyama K; Yamanaka Y; Nakajima K; Hirano T
    Oncogene; 1997 Feb; 14(7):751-61. PubMed ID: 9047382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytokine receptor signalling.
    Ihle JN
    Nature; 1995 Oct; 377(6550):591-4. PubMed ID: 7566171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of the tyrosine kinase JAK2 in signal transduction by growth hormone.
    Carter-Su C; Rui L; Herrington J
    Pediatr Nephrol; 2000 Jul; 14(7):550-7. PubMed ID: 10912517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Jak-STAT pathway.
    Imada K; Leonard WJ
    Mol Immunol; 2000; 37(1-2):1-11. PubMed ID: 10781830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.